Abbott Laboratories share price logo

Abbott Laboratories

NYSE: ABT

Large Cap

$101.29

+0.22

(+0.22%)

as on

Abbott Laboratories Stock Performance

as on September 26, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $100.09
    $101.82
    downward going graph

    1.18%

    Downside

    0.52%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $81.97
    $135.45
    downward going graph

    19.07%

    Downside

    33.72%

    Upside

    downward going graph

Abbott Laboratories share price movements today

Previous Close
$101.07
Open
$100.81
Volume
5.0M
Market Cap
$179.4B
Dividend Yield
2.40%
Day's Low - High
$100.09 - $101.82
52 Week Low - High
$81.97 - $135.45

Abbott Laboratories Historical Returns

1 Month Return
-11.23 %
3 Month Return
+ 7.62 %
1 Year Return
-24.16 %
3 Year Return
+ 5.26 %
5 Year Return
-18.56 %

Abbott Laboratories Stock Fundamentals & Key Indicators

Check Abbott Laboratories market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$179.4B

EPS (TTM)

3.11

Dividend Yield

2.40%

Quarterly Earnings Growth YOY

-0.47%

PE Ratio (TTM)

32.5

Industry PE ratio

23.69

PEG Ratio

-0.5292704537334761

EBITDA

9.9B

Revenue (TTM)

46.6B

Profit Margin

56.80%

Return On Equity TTM

10.52%

Abbott Laboratories Stock Valuation

Track how Abbott Laboratories P/E has moved over time to understand its valuation trends.

Abbott Laboratories in the last 5 years

  • Overview

  • Trends

Lowest (14.75x)

December 31, 2024

Industry (23.69x)

December 31, 2025

Today (33.50x)

December 31, 2025

Highest (35.33x)

December 31, 2021

LowHigh

Today’s Price to Earnings Ratio: 33.50x

Abbott Laboratories vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Abbott Laboratories with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$179.4B-18.56%32.556.80%2.40%
StrongBuy$648.7B65.02%31.2967.91%1.96%
Buy$159.2B-34.75%37.5771.32%6.10%

Stock Returns calculator for Abbott Laboratories Stock including INR - Dollar returns

The Abbott Laboratories stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Abbott Laboratories investment value today

Current value as on today

₹81,870

Returns

-₹18,130

(-18.13%)

Returns from Abbott Laboratories Stock

-₹24,156 (-24.16%)

Dollar Impact

₹6,026 (+6.03%)

Analyst Recommendation on Abbott Laboratories Stock

Based on 9 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 9 analysts, 100% of analysts recommend a 'BUY' rating for Abbott Laboratories. Average target price of $120.26

Abbott Laboratories Share Price Target

Get share price movements and forecasts by analysts on Abbott Laboratories.

What analysts predicted

15.77%UPSIDE

Target Price

$120.26

Current Price

$101.29

Analyzed by

9 Analysts

High

$135

Target

$120.26

Low

$112

Abbott Laboratories target price $120.26, a slight upside of 15.77% compared to current price of $101.29. According to 9 analysts rating.

Indian Investors' Interest in Abbott Laboratories Stock

Investment in Abbott Laboratories Shares on INDmoney has dropped by -8.07% in the last 30 days, indicating reduced investment activity.

Time period: to

Change:-8.07% versus previous 30 day period

Search interest for Abbott Laboratories Stock has decreased by -5% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-5% versus previous 30 day period

Abbott Laboratories Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
9,964
10,377
10,635
10,974
10,358
11,142
11,369
11,459
11,164
12,593
Gross Profit
5,022
5,305
5,426
5,598
5,444
6,288
6,338
6,537
6,283
7,304
Operating Income
1,385
1,686
1,818
1,990
1,688
2,052
2,057
2,251
1,842
1,782
EBITDA
2,358
2,580
2,907
2,989
2,668
3,048
3,092
2,822
2,247
1,782
Interest Expense
117
168
166
152
134
121
44
120
174
299
Depreciation
805
805
801
807
756
777
791
422
730
-
Income Before Tax
1,436
1,607
1,940
2,030
1,778
2,150
2,180
2,358
1,449
1,524
Income Tax Expense
211
305
294
-7,199
453
371
536
582
372
596
Net Income
1,225
1,302
1,646
9,229
1,325
1,779
1,644
1,776
1,077
928
Net Profit Margin
50.40%
51.12%
51.02%
51.01%
52.56%
56.44%
55.75%
57.05%
56.28%
58.00%

Abbott Laboratories Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
27,390
30,578
31,904
34,608
43,075
43,653
40,109
41,950
44,328
Gross Profit
13,066
15,823
16,693
17,377
23,214
22,323
20,037
21,325
24,607
Operating Income
1,972
3,844
4,591
5,291
9,200
8,362
6,435
6,825
8,048
EBITDA
6,132
6,880
7,909
9,003
12,159
11,888
10,605
10,834
11,553
Interest Expense
880
729
818
708
410
315
698
603
341
Depreciation
3,021
3,278
3,014
3,327
3,538
3,267
3,243
3,218
2,746
Income Before Tax
2,231
2,873
4,077
4,968
8,211
8,306
6,664
7,013
8,466
Income Tax Expense
1,878
539
390
497
1,140
1,373
941
-6,389
1,942
Net Income
477
2,368
3,687
4,495
7,071
6,933
5,723
13,402
6,524
Net Profit Margin
47.70%
51.75%
52.32%
50.21%
53.89%
51.14%
49.96%
50.83%
55.51%

Abbott Laboratories Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
1,225
1,302
1,646
9,229
1,325
1,779
1,644
1,776
1,077
928
Operating Cash Flow
1,025
1,960
2,705
2,868
1,417
2,047
2,787
3,315
1,315
2,488
Investing Cash Flow
-425
-453
-594
-866
-470
-582
-457
-913
-20,324
-673
Financing Cash Flow
-1,176
-791
-1,576
-1,861
-2,055
-1,097
-1,760
-1,397
17,313
-3,518
Change in Cash
-612
703
571
58
-1,084
419
560
1,011
-1,719
-1,699

Abbott Laboratories Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
477
2,368
3,687
4,495
7,071
6,933
5,723
13,402
6,524
Operating Cash Flow
5,570
6,300
6,136
7,901
10,533
9,581
7,261
8,558
9,566
Investing Cash Flow
-9,618
-1,356
-1,815
-2,215
-2,008
-1,740
-3,133
-2,338
-2,422
Financing Cash Flow
-5,281
-10,391
-4,289
-2,779
-5,494
-7,636
-7,091
-5,404
-6,309
Change in Cash
-9,213
-5,563
16
2,978
2,961
83
-2,986
720
906

Mutual Funds that own Abbott Laboratories Stock

Check out the Mutual Funds with significant holdings in Abbott Laboratories.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
6.789155%
117478412
Fidelity Concord Street Trust
1.733161%
29990342
VANGUARD SPECIALIZED FUNDS
1.312169%
22705554
Washington Mutual Investors Fund
0.925153%
16008699
JPMorgan Trust II
0.710474%
12293940

Global Institutional Holdings in Abbott Laboratories

Funds
Holdings
Vanguard
8.99%
VANGUARD INDEX FUNDS
6.79%
iShares
5.1%
SPDR
4.15%
Schwab
2.68%

Abbott Laboratories News & Key Events

  • img

    Today's Timeline - 24 September

    Thu, 06:40 PM

    -

    Abbott faces competition and slow recovery in Nutrition segment, with shares down 22.37% over the past year.

    Fri, 02:30 AM

    -

    Abbott closed at $101.07, down 2.34%, lagging behind the market; upcoming earnings forecast shows potential growth.

Insights on Abbott Laboratories

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Abbott Laboratories has shown positive revenue growth over the last two quarters. The revenue increased from $11.16 billion to $12.59 billion, with an average increase of 11.4% per quarter.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Johnson & Johnson has given 50.9% return, outperforming this stock by 75.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Johnson & Johnson has given 70.6% return, outperforming this stock by 65.3%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Abbott Laboratories has experienced a decline in its net profit over the last three quarters. The net profit dropped from $1.77 billion to $927.99 million, which reflects an average decrease of 26.6% each quarter.

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, ABT stock has moved down by -11.2%

About Abbott Laboratories

Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.
OrganisationAbbott Laboratories
Headquarters100 Abbott Park Road, Abbott Park, IL, 60064-6400, US
IndustryMedical - Devices
CEORobert Ford
E-voting on sharesClick here to vote

Key Management of Abbott Laboratories

Name

Title

Mr. Christopher J. Scoggins

Executive Vice President of Diabetes Care

Ms. Sabina Ewing

Senior VP of Business & Technology Services and Chief Information Officer

Mr. Michael Comilla

Vice President of Investor Relations.

Erica L. Battaglia

VP and Chief Ethics & Compliance Officer

Ms. Elizabeth C. Cushman

Executive VP, General Counsel & Secretary

Mr. Robert B. Ford

Executive Chairman & CEO

Mr. Philip P. Boudreau

CFO & Executive VP of Finance

Mr. Daniel Gesua Sive Salvadori

Executive VP and Group President of Established Pharmaceuticals & Nutritional Products

Ms. Lisa D. Earnhardt

Executive VP & Group President of Medical Devices

Ms. Melissa Brotz

Senior Vice President of Global Marketing & External Affairs

FAQs

What is Abbott Laboratories share price today?

Abbott Laboratories share price today is $101.29 as on at the close of the market. Abbott Laboratories share today touched a day high of $101.82 and a low of $100.09.

What is the 52 week high and 52 week low for Abbott Laboratories share?

Abbott Laboratories share touched a 52 week high of $135.45 on and a 52 week low of $81.97 on . Abbott Laboratories stock price today i.e. is closed at $101.29,which is 25.22% down from its 52 week high and 23.57% up from its 52 week low.

What is Abbott Laboratories's market capitalisation today?

Abbott Laboratories market capitalisation is $0.18T as on .

How to invest in Abbott Laboratories Stock (ABT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Abbott Laboratories on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Abbott Laboratories Shares that will get you 0.0148 shares as per Abbott Laboratories share price of $101.29 per share as on September 26, 2026 at 8:46 am IST.

What is the minimum amount required to buy Abbott Laboratories Stock (ABT) from India?

Indian investors can start investing in Abbott Laboratories (ABT) shares with as little as ₹95.819999694824 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.20 in Abbott Laboratories stock (as per the Rupee-Dollar exchange rate as on ). Based on Abbott Laboratories share’s latest price of $101.29 as on September 26, 2026 at 8:46 am IST, you will get 0.0987 shares of Abbott Laboratories. Learn more about fractional shares .

What are the returns that Abbott Laboratories has given to Indian investors in the last 5 years?

Abbott Laboratories stock has given -18.56% share price returns and 29.49% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?